- Home
- AUPH vs UTL Comparison
AUPH vs UTL Comparison
Compare AUPH & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- UTL
- Stock Information
- Founded
- AUPH 1993
- UTL 1984
- Country
- AUPH Canada
- UTL United States
- Employees
- AUPH N/A
- UTL N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- UTL Power Generation
- Sector
- AUPH Health Care
- UTL Utilities
- Exchange
- AUPH Nasdaq
- UTL Nasdaq
- Market Cap
- AUPH 1.1B
- UTL 842.0M
- IPO Year
- AUPH 1999
- UTL N/A
- Fundamental
- Price
- AUPH $7.59
- UTL $52.52
- Analyst Decision
- AUPH Strong Buy
- UTL Hold
- Analyst Count
- AUPH 2
- UTL 1
- Target Price
- AUPH $11.50
- UTL $55.00
- AVG Volume (30 Days)
- AUPH 1.6M
- UTL 72.2K
- Earning Date
- AUPH 07-31-2025
- UTL 08-05-2025
- Dividend Yield
- AUPH N/A
- UTL 3.43%
- EPS Growth
- AUPH N/A
- UTL N/A
- EPS
- AUPH 0.27
- UTL 2.93
- Revenue
- AUPH $247,295,000.00
- UTL $486,900,000.00
- Revenue This Year
- AUPH $12.15
- UTL $16.37
- Revenue Next Year
- AUPH $18.31
- UTL $5.20
- P/E Ratio
- AUPH $28.53
- UTL $17.93
- Revenue Growth
- AUPH 29.20
- UTL N/A
- 52 Week Low
- AUPH $5.20
- UTL $50.47
- 52 Week High
- AUPH $10.67
- UTL $63.52
- Technical
- Relative Strength Index (RSI)
- AUPH 40.36
- UTL 46.01
- Support Level
- AUPH $7.29
- UTL $51.17
- Resistance Level
- AUPH $8.86
- UTL $53.29
- Average True Range (ATR)
- AUPH 0.34
- UTL 1.12
- MACD
- AUPH -0.06
- UTL 0.14
- Stochastic Oscillator
- AUPH 19.37
- UTL 63.96
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About UTL UNITIL Corporation
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.